Alzheimer’s Therapeutic Research Institute
About the Institute
The Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC is an academic institute comprised of an unmatched group of expert scientific collaborators committed to advancing the development of new treatments for Alzheimer’s disease (AD) through innovation in clinical trials.
Located in San Diego, the institute is an integral part of the Keck School of Medicine of USC’s mission to create a leading hub of basic, translational and clinical research in neuroscience and neurological diseases by collaborating with sites and investigators around the world. USC ATRI promotes extensive collaboration and data sharing across academia, industry, regulators and advocacy groups with a focus on training future leaders in AD clinical research.
USC ATRI is funded by the National Institutes of Health (NIH), the Alzheimer’s Association, the Department of Defense, the pharmaceutical partners and advocacy groups to develop novel methods and engage in all phases of AD clinical trials as well as observational studies. Bringing broad expertise to a comprehensive array of partners, USC ATRI manages a portfolio of national and international multi-site studies.
Learn more about ATRI
USC ATRI holds second annual Partnership MeetingThe USC Alzheimer’s Therapeutic Research Institute (USC ATRI) held its second annual Partnership Meeting in San Diego recently. The meeting, which was attended by 125 clinical trial protocol investigators and other trial staff who work closely with USC ATRI, brought together top researchers from around the country to collaborate and discuss methods for finding effective
View All ATRI Events
Keck School Events
Children’s Hospital Los Angeles, Saban Auditorium, 4661 Sunset Blvd, Los Angeles, CA 90027
12:00 pm - 1:00 pm